SCHEMBL14223296

SCHEMBL14223296

COC(=O)c1sc(-c2ccc(C(C)=O)s2)cc1N(C(=O)c1ccc(Cl)cc1Cl)C(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.39
▸ MAPT P10636 4/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ FLT1 P17948 2/20 0.36
▸ FLT4 P35916 2/20 0.36
▸ KDR P35968 2/20 0.36
▸ MRGPRX4 Q96LA9 1/20 0.36
▸ PGK1 P00558 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2253558 0.90 SMN1; SMN2 (0.36) MAPTKDM4EALDH1A1HPGDCYP3A4
SCHEMBL2158238 0.84 MAPT (0.50) RAB9AMAPTNPC1KDM4ECASP3
SCHEMBL4157913 0.82 FLT1 (0.39) RAB9AMAPTNPC1KDM4ECASP3
SCHEMBL1961039 0.82 FLT1 (0.39) RAB9AMAPTNPC1KDM4ECASP3
SCHEMBL2158331 0.79 TSHR (0.39) KDM4EALDH1A1CYP3A4SLC6A2SLC6A4
SCHEMBL14043169 0.78 MAPT (0.44) RAB9AMAPTNPC1KDM4ECASP3
SCHEMBL4159892 0.78 MAPT (0.45) RAB9AMAPTNPC1KDM4EALDH1A1
SCHEMBL4147674 0.77 MAPT (0.42) RAB9AMAPTNPC1KDM4ECASP3
SCHEMBL1958399 0.76 FLT1 (0.35) RAB9AMAPTNPC1KDM4ECASP3
SCHEMBL4732198 0.75 MAPT (0.48) RAB9AMAPTNPC1KDM4ECASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008043791-A2 THIOPHENE DERIVATIVES FOR TREATING HEPATITIS C SMITHKLINE BEECHAM CORPORATION (US) 2008-04-17 — — WO disclosed
Send feedback